Strong October for GenMark, Myriad Stocks Lead GWDN Index Rise | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of GenMark Diagnostics and Myriad Genetics rose more than 20 percent each in October, to lead the 34 stocks that comprise the GenomeWeb Daily News Index.

Overall, the Index gained 5 percent — less than the Nasdaq, which was up 6 percent for October, but outperforming the Nasdaq Biotech Index, which rose nearly 4 percent, and the Dow Jones Industrial Average, which gained 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.